CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines

Environmental Toxicology and Pharmacology

Volumn 2, Issue 4, 1996, Pages 381-388

  Gervot, Laurence ^a   Carrière, Veronique ^a   Costet, Philippe ^a   Cugnenc, Paul Henri ^b   Berger, Anne ^b   Beaune, Philippe H ^a   De Waziers, Isabelle ^a  

^a INSERM   (France)

^b Hopital Laennec   (France)

Author keywords

Colonic cell line; CYP3Q; Human colon; Rifampicin induction

Indexed keywords

CYTOCHROME P450; ISOENZYME; MESSENGER RNA; RIFAMPICIN;

ADULT; AGED; ARTICLE; CELL LINE; COLON; COLON ADENOCARCINOMA; COLON DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030596001     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(96)00075-0     Document Type: Article

References (48)

1. Aoyama, T., S. Yamano, D. Waxman, D. Lapenson, U. Meyer, V. Fisher, R. Tyndale, T. Inaba, W. Kalow, H. Gelboin and F. Gonzalez, 1989, Cytochrome P450 hPCN3, a novel cytochrome P450IIIA gene product that is differentially expressed in adult human liver, J. Biol. Chem. 264, 10388.
2. Beaune, P., P. Kremers, F. Letawe-Goujon and J. Gielen, 1985, Monoclonal antibodies against human liver cytochrome P450, Biochem. Pharmacol. 34, 3547.
3. Beaune, P., D. Umbenhauer, R. Bork, R. Lloyd and F. Guengerich, 1986, Isolation and sequence determination of cDNA clone related to human cytochrome P-450 nifedipine oxidase, Proc. Natl. Acad. Sci. 83, 8064.
4. Bonfils, C., M. Daujat, M. Chevron and I. Dalet-Beluche, 1994, Electro-transfert of microsomal cytochromes P450 after isoelectric focusing (IEF blots): resolution of human 2A and 3A isoenzymes, Anal. Biochem. 218, 80.
5. Bork, R., T. Muto, P. Beaune, P. Srivastava, R. Lloyd and F. Guengerich, 1989, Characterisation of mRNA species related to human liver cytochrome P450 nifedipine oxidase and the regulation of catalytic activity, J. Biol. Chem. 264, 910.
6. Carrière, V., I. de Waziers, Y.A. Courtois, J.P. Leroux and P.H. Beaune, 1992, Cytochrome P450 induction and mutagenicity of 2-aminoanthracène (2AA) in rat liver and gut, Mut. Res. 268, 11.
7. Carrière, V., T. Lessufleur, A. Barbat, M. Rousset, E. Dussaulx, P. Costet, I. de Waziers, P. Beaune and A. Zweibaum, 1994, Expression of P-450 3A in HT29-MTX cells and Caco-2 clone TC7, FEBS Lett. 355, 247.
8. Chantret, I., A. Rodolosse, A. Barbat, E. Dussaulx, E. Brot-Laroche, A. Zweibaum and M. Rousset, 1994, Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line CaCo2: evidence for a glucose dependant negative regulation, J. Cell. Sci. 107, 213.
9. Combalbert, J., I. Fabre, G. Fabre, I. Dalet, J. Derancourt, J. Cano and P. Maurel, 1989, Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxydase) as a product of P450 3A gene subfamily, Drug. Metab. Dispos. 17, 197.
10. Daujat, M., I. Fabre, D. Diaz, L. Pichard, G. Fabre, J. Fabre, B. Saint Aubert and P. Maurel, 1990, Inducibility and expression of class IA and IIIA cytochromes P450 in primary cultures of adult human hepatocytes, Biochem. Pharmacol. 9, 315.
11. De Waziers, I., P. Cugnenc, C. Yang, J.P. Leroux and P. Beaune, 1990, Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues, J. Pharmacol. Exp. Ther. 253, 387.
12. De Waziers, I., P. Cugnenc, A. Berger, J.P. Leroux and P. Beaune, 1991, Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples, Carcinogenesis 12, 905.
13. De Waziers, I., J. Bouguet, P. Beaune, F. Gonzalez, B. Ketterer and R. Barouki, 1992, Effect of ethanol, dexamethasone and RU486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase π in rat hepatoma cell line (Fao), Pharmacogenetics 2, 12.
14. Ged, C., J.M. Rouillon, L. Pichard, J. Combalbert, N. Bressot, P. Bories, H. Michel, P. Beaune and P. Maurel, 1989, The increase in urinary excretion of 6 β-hydroxycortisol as a marker of human hepatic cytochrome P450 IIIA induction, Br. J. Clin. Pharmacol. 28, 373.
15. Gonzalez, F.P., 1992, Human cytochromes P450: problems and prospects, Trends Physiol. Sci. 13, 346.
16. Guengerich, F.P. and T. Shimada, 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes, Chem. Res. Toxicol. 4, 391.
17. Hakkola, J., M. Pasanen, R. Purkunen, S. Saarikoski, O. Pelkonen, J. Maenpaa, A. Rane and H. Raunio, 1994, Expression of xenobiotic metabolizing cytochromes P450 forms in human adult and fetal liver, Biochem. Pharmacol. 48, 59.
18. Kitada, M., M. Taneda, K. Ohta, K. Nagashima, K. Itahashi and T. Kamataki, 1990, Metabolic activation of aflatoxin B1 and 2-amino-3-methylimidazo(4,5-f)-quinoline by human adult and fetal liver, Cancer Res. 50, 2641.
19. Kolars, J., P. Schmiedlin-Ren, J. Schuetz, C. Fang and B. Watkins, 1992, Identification of rifampicin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes, J. Clin. Invest. 90, 1871.
20. Kolars, J., K. Lown, P. Schmiedlin-Ren, C. Ghosh M, Fang, S. Wrighton, R. Merion and P. Watkins, 1994, CYP3A gene expression in human gut epithelium, Pharmacogenetics 4, 247.
21. Komori, M., K. Nishio, M. Kitada, K. Shiramatzu, K. Muroya, M. Soma, K. Magashima and T. Kamataki, 1990, Fetus-specific expression of cytochrome P-450 in human fetal liver, Biochemistry 29, 4430.
22. Leammli, U.K., 1970, Cleavage of structural properties during the assembly of the head of the bacteriophage T4, Nature 227, 680.
23. Lessufleur, T., A. Barbat, J. Luccioni, M. Beaumatin, A. Claire, E. Kornovski, E. Dussaulx and A. Zweibaum, 1991, dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells, J. Cell. Biol. 115, 1409.
24. Lewis, A., D. Lau, G. Duran, C. Wolf and B. Sikic, 1992, Role of cytochrome P450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes, Cancer Res. 52, 4379.
25. McKinnon, R., W. Burgess, P. de la M. Hall, Z. Abdul-Aziz and M. McManus, 1992, Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P450 3A protein in the presence of flavonoides, Cancer Res. 52, 2108s.
26. McKinnon, R., W. Burgess, P. Hall, S. Robert-Thomson, F. Gonzalez and M. McMannus, 1995, Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues, Gut 36, 259.
27. Molowa, D., E. Schuetz, S. Wrighton, P. Watkins, P. Kremers, G. Mendez-Picon, G. Parker and P. Guzelian, 1986, Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver, Proc. Natl. Acad. Sci. USA, 83, 5311.
28. Morel, F., P. Beaune, D. Ratanasavanh, J.P. Flinois, C. Yang, F.P. Guengerich and A. Guillouzo, 1990, Expression of cytochrome P450 3A enzyme in cultured human hepatocytes, Eur. J. Biochem. 191, 437.
29. Murray, G., T. Barnes, H. Sewell, S. Ewen, W. Melvin and M. Burke, 1988, The immunocytochemical localisation and distribution of cytochrome P450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P450, Br. J. Clin. Pharmacol. 25, 465.
30. Omura, T. and R. Sato, 1964, The carbon monoxide binding pigment of liver microsomes, J. Biol. Chem. 239, 2379.
31. Paine, A.J., 1995, Heterogeneity of cytochrome P450 and its toxicological significance, Human Exp. Toxicol. 14, 1.
32. Peyronneau, M., J. Renaud, M. Jaouen, P. Urban, C. Cullin, D. Pompon and D. Mansuy, 1993, Expression in yeast of three allelic cDNAs coding for human liver P-4503A4, Eur. J. Biochem. 218, 355.
33. Schuetz, J., D. Molowa and P. Guzelian, 1989, Characterisation of a cDNA encoding a new member of the glucocorticoid-responsive cytochrome P450 in human liver, Arch. Biochem. Biophys. 274, 355.
34. Schuetz, E., J. Schuetz, S. Strom, M. Thompson, R. Fisher, D. Molowa, D. Li and P. Guzelian, 1993, Regulation of human liver cytochrome P-450 in family 3A in primary and continuous culture of human hepatocytes, Hepatology 18, 1254.
35. Schuetz, J.D., D.L. Beach and P.S. Guzelian, 1994, Selective expression of cytochrome P450 mRNAs in embryonic and adult human liver, Pharmacogenetics 4, 11.
36. Shimada, T. and F. Guengerich, 1989, Evidence for cytochrome P450 NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver, Proc. Natl. Acad. Sci. USA 86, 462.
37. 5, Gene 125, 49.
38. Ueng, Y., T. Shimada, H. Yamazaki and F. Guengerich, 1995, Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes, Chem. Res. Toxicol. 8, 218.
39. Walker, D., J.P. Flinois, S. Monkman, C. Belloc, A. Boddy, S. Cholerton, A. Daly, M. Lind, A. Pearson, P. Beaune and J. Idle, 1994, Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide, Biochem. Pharmacol. 47, 1157.
40. Watkins, P., S. Wrighton, P. Maurel, E. Schuetz, G. Mendez-Picon, G. Parker and P. Guzelian, 1985, Identification of an inducible form of cytochrome P-450 in human liver, Proc. Natl. Acad. Sci. USA 82, 6310.
41. Watkins, P., S. Wrighton, E. Schuetz, D. Molowa and P. Guzelian, 1987, Identification of glucocorticoid-inducible cytochromes P450 in intestinal mucosa of rats and man, J. Clin. Invest. 80, 1029.
42. Wrighton, S., B. Ring, P. Watkins and M. Vandenbranden, 1989, Identification of a polymorphically expressed member of the human cytochrome P450IIIA familly, Mol. Pharmacol. 36, 97.
43. Wrighton, S., W. Brian, M. Sari, M. Iwasaki and F.P. Guengerich, L. Raucy, D. Molowa, M. Vandenbranden, 1990, Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3), Mol. Pharmacol. 38, 207.
44. Yamazaki, H., Y. Inui, S. Wrighton, F.P. Guengerich and T. Shimada, 1995, Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes, Carcinogenesis 16, 2167.
45. Zhiri, A., H. Mayer, V. Michaud, M. Wellman-Bednawska and G. Siest, 1986, 6 beta-hydroxycortisol in serum and urine as determined by enzyme immunoassay on microtitre plates, Clin. Chem. 32, 2094.
46. Zhiri, A., M. Wellman-Bednawska and G. Siest, 1987, Le 6 beta-hydroxycortisol: un reflet non invasif des enzymes du métabolisme des médicaments, Pathol. Biol. 35, 1087.
47. Zhou-Pan, X., E. Sérée, X. Zhou, M. Placidi, P. Maurel, Y. Barra and R. Rahmani, 1993, Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interaction, Cancer Res. 53, 5121.
48. Zweibaum, A., M. Pinto, A. Barbat, E. Dussaulx, N. Triadou, B. Lacroix, K. Haffen, J.L. Brun and M. Rousset, 1985, Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT29 selected for growth in sugar free medium and its inhibition by glucose, J. Cell. Physiol. 122, 21.